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ABSTRACT
Genome-wide techniques such as microarray
analysis, Serial Analysis of Gene Expression (SAGE),
Massively Parallel Signature Sequencing (MPSS),
linkage analysis and association studies are used
extensively in the search for genes that cause dis-
eases,andoftenidentifymanyhundredsofcandidate
disease genes. Selection of the most probable of
these candidate disease genes for further empirical
analysis is a significant challenge. Additionally, iden-
tifying the genes that cause complex diseases is
problematic due to low penetrance of multiple con-
tributing genes. Here, we describe a novel bioinform-
atic approach that selects candidate disease genes
according to their expression profiles. We use the
eVOC anatomical ontology to integrate text-mining
of biomedical literature and data-mining of available
humangeneexpressiondata.Todemonstratethatour
methodissuccessfulandwidelyapplicable,weapply
it to a database of 417 candidate genes containing 17
known disease genes. We successfully select the
known disease gene for 15 out of 17 diseases and
reduce the candidate gene set to 63.3% (618.8%)
of its original size. This approach facilitates direct
association between genomic data describing gene
expression and information from biomedical texts
describing disease phenotype, and successfully
prioritizescandidategenesaccordingtotheirexpres-
sion in disease-affected tissues.
INTRODUCTION
Many diseases are thought to be caused by altered gene
function, and familial studies conﬁrm the heritability of
these diseases. Understanding genetic changes that cause
disease has potential diagnostic, prognostic and therapeutic
beneﬁts.Manydiseasephenotypesaremonogenic(Mendelian)
traits for which single causative genes have been identiﬁed.
However, complex trait phenotypes are controlled by multiple
genes, and identifying these gene loci is confounded by many
factors including locus heterogeneity, epistasis and pleiotropy,
low penetrance of contributing genetic variants (1), variable
gene expression levels and potential environmental effects on
the disease state (2). Loci are generally large, containing up to
300 genes in humans (3–5).
Two strategies are commonly used to detect candidate
disease-causing genes. The ‘candidate gene’ approach looks
for statistical correlation between genetic variants and a dis-
ease according to data derived from experimental studies, and
is favoured for simple study design and greater statistical
power to detect several genes of small effect (4,6). Alternat-
ively, the entire genome is scanned for disease genes,
frequently employing human linkage data from concordant
and discordant sib-pairs (2,6,7), with the generic problem
that such high-throughput scans analysing thousands of
genes may detect several hundred candidate genes. The
same problem is encountered with other genome-wide tech-
niques such as microarray analysis, Serial Analysis of Gene
Expression (SAGE) and Massively Parallel Signature Sequen-
cing (MPSS), which similarly generate large candidate gene
sets. The challenge, and the problem we address here, is ana-
lysis of the set of several hundred candidate genes selected by
linkage analysis and selection of a smaller subset of most
probable candidate genes before embarking on expensive
and time-consuming empirical analysis.
Analysis of candidate disease genes identiﬁed by genome-
wide analysis has traditionally taken place at the laboratory
bench in a laborious process of experimental elimination.
Bioinformatic approaches allow ‘in silico’ analysis of can-
didate genes through integration and analysis of relevant
information from many sources, including single nucleotide
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doi:10.1093/nar/gki296polymorphism (SNP) data; protein–protein interactions, gene
regulatory networks, gene structure variation, homologs,
orthologs and expression data (3,4,6,8–11). Gene expression
proﬁles are increasingly analysed in the search for candidate
disease genes, as disease gene expression is often dysregulated
in affected tissues (2,12). Examples include the use of gene
expression data to identify a gene causing Leigh Syndrome in
humans (13), and to reduce candidate gene lists for retinopath-
ies (14) and the rat Rf-1 disease (15). We have developed and
tested a generic approach to ﬁlter candidate genes selected
from disease-associated loci, according to their expression
proﬁle. We use an anatomical ontology to integrate text-
mining of scientiﬁc literature and data-mining of gene expres-
sion data to identify candidate disease genes. We use
text-mining of PubMed abstracts to identify association
between the disease name and anatomy terms. We then use
the identiﬁed anatomy terms to independently identify genes
that are expressed in these tissues from the Ensembl genomic
database (http://www.ensembl.org).
Ontologies deﬁne terms within a speciﬁc subject area
(16,17). The Uniﬁed Medical Language System (UMLS,
http://umlsks.nlm.nih.gov) is a repository of biomedical
vocabularies developed by the US National Library of
Medicine aiming to standardize terminology, such as naming
of genes, proteins, diseases and molecular functions, and
includes Medical Subject Headings (MeSH), which has a clin-
ical bias (18). The Gene Ontology (GO) describes molecular
function, process and location of action of a protein in a gen-
ericcell(19).TheeVOContologies(20)providesimplesetsof
controlled terms describing human anatomical systems, cell
types, diseases and developmental stages. Organized as an
intuitive and simple hierarchy, the terms in the anatomical
system ontology provide a human-readable description of
the terms commonly used in the annotation of samples
taken for expression studies. In addition, the standardized
terminology and hierarchical organization of the terms
make the ontology computationally parseable. Annotation
of the publicly available EST and mRNA data with terms
from the ontology provides a means to connect expressed
sequences with terms describing the location and timing of
expression. These terms can also be found in the public
literature. By using the ontologies to mine the public literat-
ure, we are able to connect expression data to the public
literature. eVOC annotation of genes and transcripts is avail-
able through the Ensmart database (http://www.ensembl.org/
Homo_sapiens/martview), and through a central site
(www.sanbi.ac.za/evoc). Here, we use the eVOC anatomical
ontology to link expression phenotype and genomic
sequence (20).
Text-mining of PubMed abstracts and articles is used
increasingly to extract molecular information from research
literature (http://www.ncbi.nlm.nih.gov/entrez/query/static/
overview.html) (21–26). However, clinical articles are under-
utilized by molecular biologists although they offer a complex
phenotype description for the disease genotype under invest-
igation. GO has been used in data- and text-mining, e.g. in the
Onto-Tools suite, an annotation database with integrated data-
mining tools (27), and Dragon TF Association Miner which
associates transcription factors with GO terms and diseases
(28). Text-mining of biomedical literature with MeSH terms
has also been used in conjunction with GO to identify
candidate disease genes (29). We use the eVOC Anatomical
System ontology as a bridging vocabulary that integrates
clinical and molecular data through a combination of
text- and data-mining, and select candidate disease genes
according to their expression proﬁles within tissues affected
by the disease of interest. We ﬁrst make an association
between each eVOC anatomy term and disease name accord-
ing to their co-occurrence in pubmed abstracts. This step does
not implicate candidate disease genes in any way. We then
rank the identiﬁed anatomy terms and select candidate genes
annotated with the top-ranking terms (Figure 1).
METHODS
Summary
We ﬁrst associate eVOC anatomy terms with disease names
based on their co-occurrence in pubmed abstracts. We then
rank the selectedanatomyterms by calculatingarankingscore
s for each associated eVOC term, according to frequency of
association and frequency of annotation of the eVOC term as
deﬁned below.ntop-scoringeVOCtermsareselected fromthe
ranked list and these terms are compared with eVOC terms
annotated to candidate disease genes selected from the
Ensembl database to populate a training dataset. Our system
allows m mismatched terms (mismatches) between the terms
identiﬁed by text-mining and the terms used to annotate
candidate genes. Genes selected from the training dataset as
the ﬁnal candidate gene list are those annotated with at least
n–m eVOC terms that match top-scoring disease-associated
eVOC terms. We apply the method with multiple values
for parameters m and n, and report the results of the optimal
values for m and n. We then use these optimal parameter
values to run the system on a second, independent dataset
(the test dataset).
Figure 1. Schema outlining the method used to identify candidate disease
genes.
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The frequency of annotation of RefSeq genes with terms from
the eVOC Anatomical System ontology was calculated for
each node (term) in the hierarchical ontology. The number
of RefSeq genes at each node was the sum of all annotated
RefSeq genes at the node and descendants of the node. The
frequency of annotation for each term is the number of RefSeq
genes at that node divided by the total number of annotated
RefSeq genes.
Frequency of association
The frequency of association of each term as it occurs with the
disease name is determined by text-mining of PubMed
abstracts using Dragon Disease Explorer (DDE, http://
research.i2r.a-star.edu.sg/DRAGON/DE/), and is the number
of abstracts containing the term and the disease name
divided by the total number of abstracts containing the disease
name.
Calculation of ranking score ‘s’
Python scripts calculate a rank score for each eVOC term
associated with a disease name, according to frequency
of association and frequency of annotation of the term.
Each associated anatomical term has a value for frequency
of association and for frequency of annotation. We empirically
determined the optimal weighting of these two values for the
calculation of the rank score by altering the weighting of
these terms and determining the effect on the ability of the
system to select known disease genes from the training
database. The optimal weighting of these values to determine
rank of eVOC terms was empirically determined to be
{rank score s = [2*f(association) + f(annotation)]/2}. The
python scripts are freely available at http://www.sanbi.ac.
za/tifﬁn_et_al. Wecalculated the frequencyof terms occurring
in PubMed abstracts that do not contain the disease name, and
found that incorporating this value in the calculation of rank
score had no effect (results not shown). n top-scoring eVOC
termsare selected fromtherankedlist andeVOC annotationof
candidate disease genes from the Ensembl database are
searched for these eVOC terms, allowing m mismatched
terms (mismatches) between the selected top-ranking terms
identiﬁed by text-mining of PubMed abstracts, and the annot-
ated terms stored in the Ensembl database for each gene.
Candidate genes from the Ensembl database that have at
least n–m annotated eVOC terms that match top-ranking
eVOC terms selected from PubMed abstracts in association
with the disease name are listed as the selected candidate
genes.
Construction of the training database
We tested our approach on a subset of genes representative of
those that might be selected by a linkage analysis study. The
sizeofthetraining databasewaschosentoapproximateasetof
such candidate genes. A training database was populated with
data for 417 genes downloaded from Ensembl EnsMart 19.3
database (www.ensembl.org). In order to select a representat-
ive set of disease genes, we ﬁrst identiﬁed various modes of
genedysregulation that may cause disease. This includedpoint
mutations in genes, mutation of the gene promoter, gene pro-
duct overexpression, gene ampliﬁcation, genetic translocation,
loss of gene imprinting, dysregulated mRNA splicing and
genes believed to predispose to disease by an unknown mech-
anism. For each type of dysregulation, we then selected one or
more known disease gene. This generated a set of 17 known
disease genes dysregulated by a large variety of genetic mech-
anisms. Depending on gene density at each disease gene locus,
5 to 10 additional genes were randomly selected from a region
of20cM aroundeach gene. To ensure sufﬁcientrepresentation
of non-disease genes in the training database in addition to the
randomly selected genes, non-disease genes were selected to
fulﬁl the categories of metabolic housekeeping genes, rRNA
genes, tRNA genes, structural and cytoskeletal genes, immune
molecules (Igs), protein family members, network members
and binding partners from the Kyoto Encyclopedia of Genes
and Genomes (KEGG) database (http://www.genome.ad.jp/
kegg/) and the preBIND database (http://www.blueprint.org/
products/prebind/prebind.html) (total = 94 genes). Again, 5 to
10 genes were selected from the same locus of each non-
disease gene and added to the training database bringing
the number of randomly selected genes to a total of 306
genes. The training database is created in MySQL with the
same structure as the Ensembl ensMART database (www.
ensembl.org/Homo_sapiens/martview), and is freely available
at http://www.sanbi.ac.za/tifﬁn_et_al.
Selecting optimal values for m and n
The system is run with all combinations of assigned
mismatched term number m (range: 0 to 5) and term number
n [range: (m + 1) to 12]. When using a value for n greater than
12, we found that few candidate genes were selected, therefore
used 12 as a maximum value. For each combination of values
for nand m,we determine the frequencywith which the known
disease gene is selected, and with which the ﬁnal set size falls
within speciﬁed limits for each pair of values used for m and n
when the system is tested with all 17 known disease genes in
the training database. In order to determine which pair of m
and n values provide useful results, the user may assign cut-off
values for frequency with which the known disease gene is
selected when all 17 diseases are analysed (true positive fre-
quency) according to the priority they wish to place on correct
selection of the known disease gene, and the frequency with
which the ﬁnal set size falls within user-speciﬁed limits (set
size frequency) according to the priority they wish to place on
reducing the size of the selected candidate set. The system is
run with all combinations of parameters m and n, and only
those pairs of values that give results fulﬁlling the required
success rates speciﬁed by true positive frequency and set size
frequency are identiﬁed. For control experiments to show that
selection of the known disease gene is not by chance, we
assign randomly selected genes from the training database
to each disease name in place of the known disease gene,
and determine whether this random gene is selected by the
method. We repeat this process ten times for each disease
name. Genes are randomly selected from the training database
using the Python pseudorandom number generator, random()
(http://docs.python.org/lib/module-random.html) and the fre-
quency with which the random gene is selected out of the ten
runs per disease is calculated. We use the Fisher Exact Test to
test whether the results from our experiment are signiﬁcantly
different from those obtained in this control experiment. As an
1546 Nucleic Acids Research, 2005, Vol. 33, No. 5additional control experiment, we address the possibility that
inclusion of the known disease gene in the selected subset is a
random event occurring only by chance. We measure the
probability of the disease gene being selected as a function
only of ﬁnal set size by calculating the value of ﬁnal set size
compared to original set size.
Validation of selected parameters
In order to verify that the system is generally applicable using
the parameters determined from the training database, we
constructed a second, independent database (the test dataset)
containingEnsembldatafor20knowndiseasegenesrandomly
selected from the OMIM database (http://www.ncbi.nlm.nih.
gov/entrez/query.fcgi?db=OMIM) and all genes falling in the
same cytogenetic bands as those disease genes (2191 addi-
tional genes). We apply the method to this independent dataset
using optimal parameter values for m and n, as determined
from running the system on the training database. The
test dataset is freely available at http://www.sanbi.ac.za/
tifﬁn_et_al/ test_dataset/).
RESULTS
Using the Anatomical System ontology, the disease gene was
correctly selected from the training database with a true pos-
itive frequency of >80% with a user-speciﬁed set size limit of
350genes(setsizefrequency>90%)whenn=4termsandm=1
mismatched term. The correct disease gene was present in the
selected subset of genes for 15/17 (88.2%) of the diseases in
the training database. We performed two control experiments.
For the ﬁrst, the average rate of selection of the assigned gene
for 10 runs with random gene assignment averages only 45%
(range: 10–80%, P = 0.0006 using the Fishers Exact Test). For
the second, we measured the likelihood that the known disease
gene is selected by chance alone, and ﬁnd that the chance of
selection of the known gene according to only the size of the
selected set was an average of only 63% (range: 31–91%)
(Figure 2). Size of candidate gene sets for the 15 successful
cases ranged from 129 to 379 (from a total of 417 genes), an
average reduction in size to 63.3% (range 30.9–90.9%) of the
original candidate gene set size (Figure 3). Here, we prioritize
inclusion of the known disease gene in the selected set by
Figure 2. Successoffindingthediseasegeneusingmismatchedtermsm=1,numberoftermsn=4isscoredassuccessful=1andunsuccessful=0(closedtriangle).
Randomlyselectedgeneswereassignedtoeachdiseasenameandtheirpresencedetectedintheselectedgeneset.Detectionrateisshownperdisease,for10runswith
random gene assignment (open circle). Likelihood of the known disease gene being selected by chance alone was calculated as the probability of the disease gene
falling into the candidate gene set according to the size of the candidate disease gene set (open square).
Nucleic Acids Research, 2005, Vol. 33, No. 5 1547specifying a true positive frequency value of >80%, selecting
only combinations of m and n that select the correct disease
gene in >80% of the 17 diseases; however, the system is
ﬂexible according to the requirements of the researcher, and
true positive frequency and set size frequency limits used to
determine parameters n and m could also be speciﬁed to pri-
oritize reduction in set size over accurate selection of the
known disease gene. Subsequent running of the method on
the independent test dataset using the parameter values
determined from the training database (m = 1 and n = 4) res-
ulted in the presence of the known disease gene in the selected
subset of candidate genes for 19/20 cases (95%), with an
average reduction in size of the candidate gene set to
64.2% (–10.7%) of the original set size (data available at
http://www.sanbi.ac.za/tifﬁn_et_al/).
The number of eVOC Anatomical System terms found
associated with each disease from the training dataset ranges
from 11to 198(Table 1),with afrequency ofassociation range
of 0.1690–0.9905. The frequency of annotation of terms to
RefSeq genes ranges from 0 to 0.928, with 55% of terms
having a value of 0 (Figure 4), indicating that not all eVOC
terms used in PubMed abstracts are used to annotate genes,
and consequently may not be informative. We found that
the number of abstracts used for text-mining did not affect
the success of the method (Table 1). Additional testing of the
method using the eVOC Cell Type and Pathology ontologies
were not successful, and this is most likely due to less frequent
annotation of genes with these terms.
We tested the validity of text-mining in identifying
disease-affected tissues by comparing the top 12 ranked
eVOC terms associated with Wilms’ tumour by text-mining
to a list of 12 tissues commonly affected in Wilms’ tumour as
provided by specialists in this ﬁeld (Dr R. D. Williams and
colleagues, Department of Paediatric Oncology, Institute of
Cancer Research, United Kingdom). Text-mining delivered
generally disease-relevantterms,with 10ofthe 12terms selec-
ted by text-mining equivalent to 7 of the 12 terms provided by
the specialists. To conﬁrm that abstracts naming the known
disease gene in conjunction with the disease name do not alter
the results of text-mining, we identiﬁed the earliest paper
in which the disease-causing gene WT1 was reported to
be mutated in a cohort of Wilms’ Tumour cases, published
in 1991 (30), and analyzed only the set of Wilms’ Tumour
abstracts published up to 1990. The three selected top-ranking
Figure 3. Reductioninsizeofthecandidategenesetsizeusingmismatchm=1andnumberoftermsn=4.Finalsetsizeisshownasapercentageofstartingsetsize.
Average and SD values are shown. *Known disease gene is not present in the selected candidate gene set.
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were found to be the same as those selected from the total
abstract set.
DISCUSSION
The system that we have designed successfully uses a
controlled vocabulary of anatomical terms, the eVOC Ana-
tomical System ontology, to match tissues associated with
disease to genes expressed in those tissues, and we demon-
strate this by successful selection of known candidate disease
genes in subsets selected from a training database of 417
genes, and an independent test dataset of 2211 genes. Our
system ﬁrst selects and ranks eVOC anatomical terms that
are found to be associated with disease names in PubMed
abstracts. Then, candidate disease genes identiﬁed by linkage
disequilibrium are selected according to their annotation in the
Ensembl database with the identiﬁed eVOC terms. Our system
succeeds in selecting the correct disease gene amongst other
candidate genes in 15 out of 17 diseases in the training dataset
(88.2% success rate). The diseases for which the candidate
gene set is most reduced (to 30.9% of original size) by our
method are chronic lymphatic leukemia in which BCL2 is
frequently overexpressed due to chromosomal translocation,
and b-thalassemia caused by mutation in the beta-globin gene
HBB. The disease for which the candidate gene set is least
Table 1. Information for each disease, showing terms associated with disease name (Associated terms), terms annotated to the disease gene (Annotated terms),
number of terms associated with disease name and also used to annotate the disease gene (Common eVOC terms), number of common terms falling within the
highest four ranking terms (Terms ranked in top 4) and total number of candidate disease genes selected
Disease Disease
gene
Number of
abstracts
Candidate
genes
Associated
terms
Annotated
terms
Common
eVOC terms
Terms ranked
in top 4
Gilberts syndrome
a UGT1A1 316 216 37 8 6 1
Waardenburg syndrome
a PAX3 213 321 57 10 5 1
Frasier syndrome WT1 36 259 11 16 4 3
Dysbetalipoproteinemia APOE 331 239 37 38 11 3
Chronic lymphatic leukemia BCL2 407 129 65 28 20 3
Bloom syndrome BLM 447 379 51 22 14 3
Beckwith Weidemann IGF2 505 292 76 22 16 3
Ankylosing spondylitis HLA-B 3451 350 137 53 38 3
Wilms tumour WT1 4764 292 152 16 15 3
Muscular dystrophy DMD 7210 142 166 40 33 3
Thalassemia HBB 7510 129 143 34 31 3
Retinoblastoma RB1 8617 334 175 35 34 3
Ovarian cancer BRCA1 11 227 238 142 25 24 3
Neuroblastoma MYCN 15 409 367 197 20 20 3
Familial hypercholesterolemia LDLR 15 506 302 159 34 31 3
Prostate cancer ERBB2 17 876 257 164 30 29 3
Breast cancer BRCA1 51 759 238 198 25 24 3
aKnown disease gene not present in candidate gene set
Figure 4. Frequency of annotation per ‘eVOC Anatomy Term’ in the EnsMart database. The frequency of RefSeq genes at each node was the sum of all annotated
RefSeq genes at the node and descendants of the node, compared to total number of annotated RefSeq genes.
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whichthe BLMgeneismutated (seeTable 1).Abstractnumber
and type of gene mutation do not affect gene selection or ﬁnal
set size. For Waardenburg Syndrome and Gilberts Syndrome,
the disease gene is not selected although it is present in the
training database, and the terms in common between disease-
associated and gene-annotated terms tend to be low ranking. In
general, higher numbers oftermsassociated with disease name
do not result in an increase in common term number, and this
suggests that the number of eVOC annotations per gene, rather
than associated term number, is the limiting factor in the
number of common terms selected. The disease genes for
Waardenburg Syndrome and Gilberts Syndrome are poorly
annotated with eVOC terms, and this is likely to have
contributed to these genes not being selected as candidates
by our method (Table 1, Figure 5).
We conﬁrm the wider applicability of this system by testing
the parameters optimized using the training database on a
second separate database, the test dataset, containing 1211
genes including 20 known disease genes. In this scenario,
the system successfully selects the known disease gene in
95% of cases, and reduces the size of the candidate gene
set to 64.2% (–10.7%) of the original set size (data available
at www.sanbi.ac.za/tifﬁn_et_al/). These results are compar-
able to those obtained with the training database. The success
rate is marginally higher for the test dataset, and the average
reduction in the set size marginally lower although with a
greatly reduced SD. Thus, the selected values for parameters
Figure 5. Schema showing the relationship between the number of candidate genes selected (Candidate genes), number of terms associated with the disease name
(Associatedterms),numberoftermsusedtoannotatethediseasegene(Annotatedterms)andnumberoftermsassociatedwithdiseasenameandalsousedtoannotate
the disease gene (Common terms). *Known disease gene is not present in the candidate gene set.
1550 Nucleic Acids Research, 2005, Vol. 33, No. 5m and n appear to be applicable to datasets beyond the training
database that was used to determine the optimal parameter
values.
The eVOC Anatomical System ontology successfully con-
nects clinical data in PubMed abstracts to the expression
proﬁles of genes. It offers the advantage of small size,
uncomplicated structure and accessible terminology that is
applicable to both clinical and molecular biology disciplines,
in contrast to more discipline-speciﬁc ontologies such as GO
and MeSH. This simplicity permits the terms selected by
text-mining using the eVOC ontology to be used directly
for data-mining genomic databases. Several other bioinform-
atic methods to identify candidate disease genes have been
recently described. Perez-Iratxeta et al. use MeSH and GO
termsinamultiple-step, inference-basedtext-anddata-mining
procedurethatcorrectlydetects55of100knowndiseasegenes
(29). This system uses text-mining of PubMed abstracts to
make associations between MeSH pathological terms and
MeSH chemical terms, and then to link the chemical terms
to GO functional annotations. Genes with those GO functional
annotationsareselected andrankedaccordingtothenumberof
terms they share. Freudenberg and Propping describe a system
that clusters known disease genes according to phenotypic
similarity between their associated diseases, and ranks can-
didate disease genes by comparing their GO annotations to
those of the clustered disease genes (31). Their system detects
the known disease gene, within a wide range of rankings, for
two-thirds of 10 672 diseases documented in OMIM. Turner
et al. describe POCUS, a system to predict candidate disease
genes according to enrichment of GO and InterPro domain
annotation for genes within a set of speciﬁed disease-
associated genetic loci (32). Depending on parameters and
thresholds applied, this system successfully identiﬁes two or
moreknowndiseasegenesfor15–65%of29complexdiseases.
In comparison to these approaches, our method avoids the
complexity of the extensive MeSH and GO vocabularies. The
eVOC anatomical terminology is simple and purely des-
criptive, and we avoid interpretational bias that may be
encountered with functional annotation systems such as
GO. Also, our method does not employ indirect inference
between terms, and the eVOC terms identiﬁed by text-
mining are used directly in gene annotation. This combination
of simplicity and direct association between biomedical texts
and genetic data, without functional interpretation, allows our
system a signiﬁcant advantage and a high success rate
(88.2%). Avoiding analysis based on gene functional annota-
tion also allows novel candidate gene selections to be made
outside current functional knowledge paradigms.
Van Driel et al. describe GeneSeeker, a web-based
application that mines up to 9 web-based databases for can-
didate genes using expression terms deﬁned by the user, and
collates positional and expression/phenotypic information to
provide an overview of the candidates (33). This system
requires some clinical knowledge by the user, and search
termsandgenedatadonotconformtoacontrolledvocabulary,
which may cause appropriate information to be missed while
searching. The system is demonstrated for ten human
malformation syndromes, but the general success rate is not
determined. In contrast, our method employs efﬁcient and
comprehensive querying ofcontrolledvocabulary terms stored
in a relational database. Also, our method provides a crucial
additional step of text-mining biomedical literature to deter-
mine appropriate anatomical sites affected in a disease
and thus allows the system to be widely applicable to all
diseasesregardlessoftype ofdisease orthe domain knowledge
of the user.
We are conﬁdent that text-mining of abstracts using disease
names and the eVOC Anatomical System terms generates
terms that are relevant to the symptoms of the disease, as
illustrated by the comparison made between terms identiﬁed
for Wilms’ tumour by our system, and terms proposed by
specialists in the ﬁeld. Although there may be occasional
terms identiﬁed by text-mining that are not disease-relevant,
our system searches for four common eVOC terms but allows
1 mismatched term to occur, and this permitted mismatch can
accommodate the effect of occasional inappropriate terms that
may be selected by text-mining.
This generic method of text- and data-mining using
ontologies offers a rapid and reliable approach to selection
of candidate disease genes according to expression proﬁle,
giving researchers a valuable starting point to prioritize can-
didates for a wide range of diseases. When compared with
existing systems to prioritize candidate disease genes, our
method has a high success rate and an approach that is unique
in its use of a simple anatomical ontology to directly associate
biomedical literature describing disease phenotype and annot-
ated gene expression data. We have avoided using functional
data due to its intrinsic interpretative nature and the complex-
ity of GO terminology. Our method is ﬂexible, and parameter
values (m and n) can be chosen to prioritize true positive
frequency or candidate gene set size reduction, according to
the researcher’s preference. Our method relies on annotation
of genes using a controlled vocabulary to integrate molecular
biology expression data and clinical disease data, and these
results emphasize that extensive application of appropriate
controlled vocabularies to biomedical data will enhance the
efﬁcacy and productivity of text- and data-mining. Where can-
didate genes are poorly annotated, future research may include
analysis of annotation of orthologous and paralogous genes,
in order to further deﬁne expression proﬁles of candidates.
To date, no single method is able to accurately predict
candidate disease genes in one step. Rather, a concert of meth-
ods is applied to prioritize most likely candidate disease genes
from sets identiﬁed by such techniques as linkage analysis and
microarray analysis. Existing methodologies mine biological
and functional information about candidate genes, and we
believe that our system can complement these existing
approaches by using a novel method that mines expression
data for candidate genes, linking this data with anatomical
sites that are implicated in the disease. By using text-
mining of PubMed abstracts, our method allows researchers
to utilize associations between disease name and affected tis-
sues without having a clinical understanding of the disease,
and to apply this data in the selection of candidate genes.
Employing the additional facet of gene expression data in
this way can signiﬁcantly assist in the process of focusing
the search for most likely disease gene candidates.
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